AAAAAA
Results:
1-7
|
Results: 7
Authors:
Webb, CP
Woude, GFV
Citation: Cp. Webb et Gfv. Woude, Animal models for Ras-induced metastasis, METH ENZYM, 333, 2001, pp. 318-329
Authors:
Duesbery, NS
Resau, J
Webb, CP
Koochekpour, S
Koo, HM
Leppla, SH
Woude, GFV
Citation: Ns. Duesbery et al., Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways, P NAS US, 98(7), 2001, pp. 4089-4094
Authors:
Furge, KA
Kiewlich, D
Le, P
Vo, MN
Faure, M
Howlett, AR
Lipson, KE
Woude, GFV
Webb, CP
Citation: Ka. Furge et al., Suppression of Ras-mediated tumorigenicity and metastasis through inhibition of the Met receptor tyrosine kinase, P NAS US, 98(19), 2001, pp. 10722-10727
Authors:
Gmyrek, GA
Walburg, M
Webb, CP
Yu, HM
You, XK
Vaughan, ED
Woude, GFV
Knudsen, BS
Citation: Ga. Gmyrek et al., Normal and malignant prostate epithelial cells differ in their response tohepatocyte growth factor/scatter factor, AM J PATH, 159(2), 2001, pp. 579-590
Authors:
Webb, CP
Woude, GFV
Citation: Cp. Webb et Gfv. Woude, Genes that regulate metastasis and angiogenesis, J NEURO-ONC, 50(1-2), 2000, pp. 71-87
Authors:
Webb, CP
Hose, CD
Koochekpour, S
Jeffers, M
Oskarsson, M
Sausville, E
Monks, A
Vande Woude, GF
Citation: Cp. Webb et al., The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-Met-urokinase plasminogen activator-plasmin proteolytic network, CANCER RES, 60(2), 2000, pp. 342-349
Authors:
Duesbery, NS
Webb, CP
Woude, GFV
Citation: Ns. Duesbery et al., MEK Wars, a new front in the battle against cancer, NAT MED, 5(7), 1999, pp. 736-737
Risultati:
1-7
|